搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Neosartorya fumigata Protein sey1 (sey1), partial CSB-YP536510NGT
CSB-EP536510NGT
CSB-BP536510NGT
CSB-MP536510NGT
CSB-EP536510NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable glucan endo-1,6-beta-glucosidase B (exgB) CSB-YP536511NGT
CSB-EP536511NGT
CSB-BP536511NGT
CSB-MP536511NGT
CSB-EP536511NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable DNA-binding protein creA (creA) CSB-YP536512NGT
CSB-EP536512NGT
CSB-BP536512NGT
CSB-MP536512NGT
CSB-EP536512NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata 1,3-beta-glucanosyltransferase gel3 (gel3) CSB-YP536513NGT
CSB-EP536513NGT
CSB-BP536513NGT
CSB-MP536513NGT
CSB-EP536513NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable E3 ubiquitin ligase complex SCF subunit sconB (sconB), partial CSB-YP536514NGT
CSB-EP536514NGT
CSB-BP536514NGT
CSB-MP536514NGT
CSB-EP536514NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Xylanolytic transcriptional activator xlnR (xlnR), partial CSB-YP536515NGT
CSB-EP536515NGT
CSB-BP536515NGT
CSB-MP536515NGT
CSB-EP536515NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Cyanate hydratase (cyn1) CSB-YP536516NGT
CSB-EP536516NGT
CSB-BP536516NGT
CSB-MP536516NGT
CSB-EP536516NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Lysophospholipase 3 (plb3), partial CSB-YP536517NGT
CSB-EP536517NGT
CSB-BP536517NGT
CSB-MP536517NGT
CSB-EP536517NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable exo-1,4-beta-xylosidase bxlB (bxlB), partial CSB-YP536518NGT
CSB-EP536518NGT
CSB-BP536518NGT
CSB-MP536518NGT
CSB-EP536518NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable beta-glucosidase I (bglI), partial CSB-YP536519NGT
CSB-EP536519NGT
CSB-BP536519NGT
CSB-MP536519NGT
CSB-EP536519NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata High osmolarity signaling protein sho1 (sho1), partial CSB-YP536520NGT1
CSB-EP536520NGT1
CSB-BP536520NGT1
CSB-MP536520NGT1
CSB-EP536520NGT1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Cytosolic Fe-S cluster assembly factor nar1 (nar1), partial CSB-YP536521NGT
CSB-EP536521NGT
CSB-BP536521NGT
CSB-MP536521NGT
CSB-EP536521NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable endopolygalacturonase A (pgaA) CSB-YP536522NGT
CSB-EP536522NGT
CSB-BP536522NGT
CSB-MP536522NGT
CSB-EP536522NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Methionine aminopeptidase 2 homolog AFUB_064000 (AFUB_064000) CSB-YP536523NGT
CSB-EP536523NGT
CSB-BP536523NGT
CSB-MP536523NGT
CSB-EP536523NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable endo-1,4-beta-xylanase C (xlnC) CSB-YP536524NGT
CSB-EP536524NGT
CSB-BP536524NGT
CSB-MP536524NGT
CSB-EP536524NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable HECT-type ubiquitin ligase-interacting protein creD (creD), partial CSB-YP536525NGT
CSB-EP536525NGT
CSB-BP536525NGT
CSB-MP536525NGT
CSB-EP536525NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable beta-glucosidase btgE (btgE), partial CSB-YP536526NGT
CSB-EP536526NGT
CSB-BP536526NGT
CSB-MP536526NGT
CSB-EP536526NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable beta-glucosidase L (bglL), partial CSB-YP536527NGT
CSB-EP536527NGT
CSB-BP536527NGT
CSB-MP536527NGT
CSB-EP536527NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Maintenance of mitochondrial morphology protein 1 (mmm1), partial CSB-YP536528NGT
CSB-EP536528NGT
CSB-BP536528NGT
CSB-MP536528NGT
CSB-EP536528NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable arabinan endo-1,5-alpha-L-arabinosidase C (abnC) CSB-YP536529NGT
CSB-EP536529NGT
CSB-BP536529NGT
CSB-MP536529NGT
CSB-EP536529NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細(xì)胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>